Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases

Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases

US Patent 11547729 · Granted Jan 10, 2023

Estimated economic value: $147,888,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of an integrated microfluidic chip for analysis of cell motility and predict2025
Systems and methods for surgical training model2025
Bioreducible poly (beta-amino ester)s for siRNA delivery2025
Microfluidic chip for analysis of cell motility and methods for using same2025
Tolerogenic artificial antigen-presenting cells2024
Biodegradable biomimetic particles2024
Multicomponent degradable cationic polymers2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Nonviral gene transfer to the suprachoroidal space2024
Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathwa2023
Ring-shaped cortical electrode assembly2023
Use of an integrated microfluidic chip for analysis of cell motility and predict2023